METHOD FOR PREDICTION OF RECURRENT EPSTEIN-BARR VIRUS INFECTION IN CHILDREN Russian patent published in 2019 - IPC G01N33/53 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to paediatrics and immunology, and can be used for prediction of recurrent EBVI in children. Method for prediction of Epstein-Barr recurrence of viral infection in children involves evaluating immunological parameters by immunoassay and in the presence of antibodies to Epstein-Barr virus class antigen of IgG class and within specified limits of absolute number of values CD3⁺ 2.1–6.2×10⁹/l, CD7⁺ 2.0–4.3×10⁹/l, CD8⁺ 0.2 -0.8×10⁹/l, the clinical manifestations of the Epstein-Barr recurrence of the viral infection are predicted.

EFFECT: proposed method is easy to reproduce, does not require high material costs, and when examining patients enables predicting the development of recurrent EBVI in children in 95–100 %.

1 cl, 2 tbl, 3 ex